- Docetaxel-Cisplatin-5-FU Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Cancer
-
Kim JH, Lee YC
- KMID: 782915
- Korean J Gastroenterol.
- 2007 Sep;50(3):207-209.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Oral Tegafur-uracil Plus Folinic Acid versus Intravenous 5-fluorouracil Plus Folinic Acid as Adjuvant Chemotherapy of Colon Cancer
-
Kim DJ, Kim TI, Suh JH, Cho YS, Shin SK, Kang JK, Kim NK, Kim WH
- KMID: 720907
- Yonsei Med J.
- 2003 Aug;44(4):665-675.
- doi: 10.3349/ymj.2003.44.4.665
To compare, in terms of compliance, toxicity, quality of life (QOL) and efficacy, intravenous 5-fluorouracil plus folinic acid with oral tegafur-uracil plus folinic acid as postoperative adjuvant chemotherapy after curative... -
- CITED
-
- Close
- SHARE
-
- Close
- Locally advanced unresectable gastric cancer successfully resected after neoadjuvant chemotherapy with FADE regimen
-
Chung HC, Roh JK, Park YJ, Lee SI, Min JS, Lee JT, Lee KB, Kim BS
- KMID: 1121425
- Yonsei Med J.
- 1990 Mar;31(1):74-79.
- doi: 10.3349/ymj.1990.31.1.74
The prognosis of unresectable advanced gastric cancer is extremely poor. We tried a neoadjuvant chemotherapy in locally advanced unresectable stomach cancer diagnosed by initial explo-laparotomy. After chemotherapy with the FADE... -
- CITED
-
- Close
- SHARE
-
- Close
- Epirubicin, Cisplatin, and Protracted Venous Infusion of 5-Fluorouracil for Advanced Gastric Carcinoma
-
Cho EK, Lee WK, Lim DY, Bang SM, Park DK, Park YH, Kwon OS, Choi DJ, Shin DB, Lee JH, Lee TH
- KMID: 1101549
- J Korean Med Sci.
- 2002 Jun;17(3):348-352.
- doi: 10.3346/jkms.2002.17.3.348
To evaluate the activity and safety of a combination chemotherapy with epirubicin, cisplatin, and a protracted venous infusion of 5-fluorouracil (ECF) in unresectable or metastatic gastric cancer, a phase II... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination Chemotherapy with 5-Fluorouracil and Heptaplatin as First-line Treatment in Patients with Advanced Gastric Cancer
-
Min YJ, Bang SJ, Shin JW, Kim DH, Park JH, Kim GY, Ko BK, Choi DH, Cho HR
- KMID: 1786814
- J Korean Med Sci.
- 2004 Jun;19(3):369-373.
- doi: 10.3346/jkms.2004.19.3.369
Heptaplatin is a recently developed platinum derivative. This agent has been reported to have a response rate of 17% as a single agent, and tolerable toxicity in the treatment of... -
- CITED
-
- Close
- SHARE
-
- Close
- Outpatient-basis Chemotherapy of Oxaliplatin, 5-fluorouracil, and Leucovorin as First-line Treatment for Patients with Metastatic or Recurrent Colorectal Cancer
-
Moon JH, Kim JG, Sohn SK, Baek JH, Cho YY, Chae YS, Ahn BM, Kim SN, Lee SJ, Lee IT, Choi GS, Jun SH
- KMID: 1778344
- J Korean Med Sci.
- 2007 Jun;22(3):400-404.
- doi: 10.3346/jkms.2007.22.3.400
The objectives of the present study were to evaluate the efficacy and safety of an outpatient-basis chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin as the first-line treatment for patients with advanced... -
- CITED
-
- Close
- SHARE
-
- Close
- The effects of intraoperative mitomycin-C or 5-fluorouracil on glaucoma filtering surgery
-
Oh SY, Youn DH, Kim DM, Hong C
- KMID: 1735115
- Korean J Ophthalmol.
- 1994 Jun;8(1):6-13.
- doi: 10.3341/kjo.1994.8.1.6
We compared the success rate of filtering surgery of a single 5-minute intraoperative application of mitomycin-C (MMC) or 5-fluorouracil (5-FU). Animal experiment and clinical study were done. In animal study,... -
- CITED
-
- Close
- SHARE
-
- Close
- Docetaxel-Cisplatin-5-FU Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Cancer
-
Kang SH, Kim JI, Goh PG, Hwang SW, Kwon DS, Nam KW, Kang HM, Kang YS, Moon HS, Kim SH, Seong JK, Lee BS, Jeong HY
- KMID: 782906
- Korean J Gastroenterol.
- 2007 Sep;50(3):157-163.
BACKGROUND/AIMS: The purpose of this study was to investigate the efficacy and safety of 'docetaxel-5-FU-cisplatin' combination chemotherapy as a first-line treatment in patients with metastatic or recurrent gastric cancer. ... -
- CITED
-
- Close
- SHARE
-
- Close
